Discover how Revvity's preclinical oncology services specializing in cell-based assay can help answer your critical drug discovery questions, from target identification to MOA studies.
Access our cell panel screening, functional genomics, immune cell screening, and cell engineering capabilities. Partner with scientists who deliver the actionable, quality data you need to make confident decisions and advance your therapeutics faster.
Download now to explore our proven capabilities.
For research use only. Not for use in diagnostic procedures.
Preclinical oncology services brochure